@ARTICLE{PARSANEZHAD, author = {PARSANEZHAD, ME and RAOOFI, M and ALBORZI, S and OMRANI, GH and }, title = {A PROSPECTIV E, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL OF DEXAMETHASONE DURING THE FOLLICULAR PHASE IN CLOMIPHENE RESISTANT PATIENTS WITH POLYCYSTIC OVARY SYNDROME AND NORMAL DHEAS}, volume = {17}, number = {3}, abstract ={In order to evaluate the effects of short course administration of dexamethasone (DEX) combined with clomiphene citrate (CC) in CC-resistant patients with polycystic ovary syndrome (PCaS) and normal DHEAS, a prospective, double blind, placebo controlled, randomized study was undertaken at referral university hospitals, Two-hundred and thirty women with PCOS and normal DHEAS who failed to ovulate with a routine protocol of CC received 200 mg of CC from day 5 to 9 and 2 mg of DEX from day 5 to 14 of the menstrual cycle. The control group received the same protocol of CC combined with placebo. Follicular development, hormonal status, ovulation rate, and pregnancy rate were evaluated. Mean follicular diameters were 18.4124±2.4314 mm and 13.8585±2.0722 mm (p }, URL = {http://mjiri.iums.ac.ir/article-1-682-en.html}, eprint = {http://mjiri.iums.ac.ir/article-1-682-en.pdf}, journal = {Medical Journal of the Islamic Republic Of Iran}, doi = {}, year = {2003} }